Results 31 to 40 of about 11,242 (227)

A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study

Radiation Oncology, 2019
Background We compared clinical outcomes of carbon ion radiotherapy and transarterial chemoembolization in the treatment of hepatocellular carcinoma. Methods Data of 477 patients with hepatocellular carcinoma who had undergone carbon ion radiotherapy or ...
Shintaro Shiba, Kei Shibuya, Hiroyuki Katoh, Takuya Kaminuma, Masaya Miyazaki, Satoru Kakizaki, Ken Shirabe, Tatsuya Ohno, Takashi Nakano   +8 more
doaj   +1 more source

Difference in Acquired Radioresistance Induction Between Repeated Photon and Particle Irradiation

Frontiers in Oncology, 2019
In recent years, advanced radiation therapy techniques, including stereotactic body radiotherapy and carbon–ion radiotherapy, have progressed to such an extent that certain types of cancer can be treated with radiotherapy alone.
Katsutoshi Sato, Takashi Shimokawa, Takashi Imai   +2 more
doaj   +1 more source

A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial

BMC Cancer, 2022
Background Some cancers such as sarcomas (bone and soft tissue sarcomas) and adenoid cystic carcinomas are considered as radioresistant to low linear energy transfer radiation (including photons and protons) and may therefore beneficiate from a carbon ...
Jacques Balosso, Olivia Febvey-Combes, Annie Iung, Hélène Lozano, Abdoulkader Soumai Alloh, Catherine Cornu, Magali Hervé, Zohra Akkal, Michel Lièvre, Valérie Plattner, Francesca Valvo, Cristina Bono, Maria Rosaria Fiore, Viviana Vitolo, Barbara Vischioni, Stéphanie Patin, Hubert Allemand, François Gueyffier, Jennifer Margier, Pascale Guerre, Sylvie Chabaud, Roberto Orecchia, Pascal Pommier   +22 more
doaj   +1 more source

Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2021
Localized hepatocellular carcinoma (HCC) that is unresectable and non-transplantable can be treated by several liver-directed therapies. External beam radiation therapy (EBRT) is an increasingly accepted and widely utilized treatment modality in this setting.
Belal Abousaida, Danushka Seneviratne, Bradford S Hoppe, Stephen J Ko, Aroumougame Asaithamby, Francis A Cucinotta, Jessica M Kirwan, Kabir Mody, Beau Toskich, Jonathan B Ashman, Christopher L Hallemeier, Sunil Krishnan   +11 more
openaire   +4 more sources

Carbon ion radiotherapy for inoperable pediatric osteosarcoma [PDF]

Oncotarget, 2018
Unresectable pediatric osteosarcoma has poor outcomes with conventional treatments.Twenty-six patients aged 11-20 years (median 16) had inoperable osteosarcoma of the trunk (24 pelvic, 1 mediastinal and 1 paravertebral) without any other lesion at initial examination. There were 22 primary, 1 locally recurrent and 3 metastatic cases.
Mohamad, Osama, Imai, Reiko, Kamada, Tadashi, Nitta, Yuki, Araki, Nobuhito   +4 more
openaire   +2 more sources

Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer

Frontiers in Oncology, 2021
PurposeEffective treatment strategies for unresectable locally advanced pancreatic cancer (LAPC) patients are eagerly warranted. Recently, convincing oncological outcomes were demonstrated by carbon ion radiotherapy.
Jakob Liermann, Jakob Liermann, Jakob Liermann, Jakob Liermann, Jakob Liermann, Patrick Naumann, Patrick Naumann, Patrick Naumann, Fabian Weykamp, Fabian Weykamp, Fabian Weykamp, Philipp Hoegen, Philipp Hoegen, Philipp Hoegen, Philipp Hoegen, Juergen Debus, Juergen Debus, Juergen Debus, Juergen Debus, Juergen Debus, Juergen Debus, Klaus Herfarth, Klaus Herfarth, Klaus Herfarth, Klaus Herfarth, Klaus Herfarth, Klaus Herfarth   +26 more
doaj   +1 more source

Particle radiotherapy with carbon ion beams [PDF]

EPMA Journal, 2013
Carbon ion radiotherapy offers superior dose conformity in the treatment of deep-seated malignant tumours compared with conventional X-ray therapy. In addition, carbon ion beams have a higher relative biological effectiveness compared with protons or X-ray beams. The algorithm of treatment planning and beam delivery system is tailored to the individual
openaire   +2 more sources

Fluorodeoxyglucose positron emission tomography (FDG/PET) shows the effect of carbon-ion radiotherapy (CIRT); with pathologic confirmation

Radiology Case Reports, 2023
Response evaluation of carbon-ion radiotherapy poses a diagnostic challenge. Due to its functional aspects, fluorodeoxyglucose positron emission tomography (FDG/PET) has a role in the diagnosis of photon radiation therapy.
Jun Aoki, MD, Yayoi Yamamoto, MD,PhD, Ayumi Horikawa, MD,PhD, Tsunehiro Doiuchi, MD, Ayako Hino, MD,PhD, Daichi Kojima, MD, Hiroaki Kurihara, MD,PhD, Kota Washimi, MD,PhD, Hiroyuki Katoh, MD,PhD, Toru Hiruma, MD,PhD   +9 more
doaj   +1 more source

Technical Note: Improving the workflow in a carbon ion therapy center with custom software for enhanced patient care

Technical Innovations & Patient Support in Radiation Oncology
Carbon-ion radiation therapy (CIRT) is an up-and-coming modality for cancer treatment. Implementation of CIRT requires collaboration among specialists like radiation oncologists, medical physicists, and other healthcare professionals.
Sridhar Yaddanapudi, Yushi Wakisaka, Keith M. Furutani, Masashi Yagi, Shinichi Shimizu, Chris J. Beltran   +5 more
doaj   +1 more source

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”

BMC Cancer, 2020
Background Carbon ion Radiotherapy for prostate cancer is widely used, however reports are limited from single institute or short follow up. We performed a prospective observational study (GUNMA0702) to evaluate the feasibility and efficacy of carbon ion
Hidemasa Kawamura, Nobuteru Kubo, Hiro Sato, Tatsuji Mizukami, Hiroyuki Katoh, Hitoshi Ishikawa, Tatsuya Ohno, Hiroshi Matsui, Kazuto Ito, Kazuhiro Suzuki, Takashi Nakano, Group for Genitourinary Tumors at Gunma University Heavy Ion Medical Center   +11 more
doaj   +1 more source